stockstotrade.comAUG 282 min read$DPZ

Domino’s Pizza DPZ Surges As Oppenheimer Sticks With Outperform Call

Domino’s Pizza (DPZ) stock rose 5.4% following strong earnings and upbeat same-store sales growth. Analysts highlight its strong unit economics, with ROA above 30%, EBIT margin ~19%, and solid free cash flow. Oppenheimer maintains an outperform rating with a $415 target, citing quality growth and reasonable valuation at ~19.5x EPS. Technical analysis points to support near $332 and resistance at $355.

Original reporting

stockstotrade.com

Published Aug 28, 2026, 8:17 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 29, 2026, 8:18 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Domino’s Pizza DPZ Surges As Oppenheimer Sticks With Outperform Call — source image — Source · stockstotrade.com

Decision brief

The 30-second read

$DPZBullishHigh

Why it matters

The earnings beat reinforces the company's growth story and may attract momentum traders.

Market read

Earnings-driven rally adds bullish bias to consumer discretionary space.

What to watch

Leverage and negative book equity could limit upside if interest rates rise.

Relevance 8/10Novelty 8/10Timing: today

Background

Domino's highlighted its franchise model, high ROA, and dividend yield as part of the earnings narrative.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$DPZBullishHigh confidence

Context

Domino's reported an earnings beat and strong same‑store sales, driving the stock up 5.4% on the day.

Expected impact

Potential further upside toward $380‑$400 if momentum holds.

Evidence & confidence

The fresh earnings numbers and dividend raise provide a concrete catalyst for short‑term buying.

Market effects

Sector

Strong earnings may lift the broader consumer discretionary and restaurant sector.

Regional

U.S. market bias toward quality consumer stocks.

Global

Limited to U.S. equities; no direct global effect.

Counterpoint

What could challenge this read

If the price rally is already priced in, a pullback to support at $332 could be expected.

Key entities

company
Domino's Pizza Inc
U.S.-listed pizza delivery chain reporting earnings.

Read at source ← All news

SEP 18

$AZOMed

Oppenheimer maintains Outperform rating on AutoZone, $3500 price target

Oppenheimer kept an Outperform rating on AutoZone with a $3500 price target, suggesting 23.1% upside from the Sep 17 close. The firm cites strategic investments to boost market share and a low forward PE multiple of 16x as reasons for the positive outlook.

tradingview.com1 min

SEP 17

$DPZMedAI 8/10

Greg Abel Exited a Consumer Brand Warren Buffett Backed for 6 Straight Quarters. Here's Why That Was the Wrong Move.

Berkshire Hathaway, under new CEO Greg Abel, sold all its Domino's Pizza (DPZ) shares this year, despite the company's long-term fundamentals remaining intact. Domino's recent sales have been weak, but it continues to gain market share and expand globally. The stock's valuation has become more attractive, with its P/E ratio dropping to 18, presenting a potential buying opportunity for long-term investors.

aol.com2 min

SEP 15

$ETSYHigh

Oppenheimer Turns Bullish on Etsy, Citing AI Search Gains and $90 Target — BigGo Finance

Oppenheimer upgraded Etsy (ETSY) to Outperform with a $90 price target, citing AI-driven search improvements and stronger user engagement. The stock rose 2.9% in premarket trading. Analyst Jason Helfstein noted positive third-quarter traffic data and high direct traffic levels, suggesting a competitive advantage. Etsy raised its full-year GMS growth outlook to a mid-single-digit range.

finance.biggo.com2 min

SEP 15

$DFTXMed

Definium Therapeutics price target raised to $75 from $70 at Oppenheimer

Oppenheimer increased its price target for Definium Therapeutics (DFTX) to $75 from $70, maintaining an Outperform rating. The firm cited positive Phase 3 trial results for DT120, which it believes support the company's potential to improve treatment for GAD patients. Oppenheimer updated its model to reflect increased optimism.

tipranks.com1 min

SEP 9

$DPZMed

Domino’s Stock Has Fallen 27% From Its 52-Week High. Here’s Why

Domino's Pizza (DPZ) stock is down 27% from its 52-week high. Q2 results showed revenue beating expectations but EPS missing, with U.S. same-store sales growth slowing to 0.1%. International sales also declined slightly. The company reaffirmed international store targets but reduced U.S. store additions due to franchisee profitability pressures. A valuation model suggests a target price of $433, implying 26.8% upside over 2.3 years. The stock trades below its 5-year average multiple, reflecting

tikr.com3 min

SEP 5

$DPZHighAI 8/10

DPZ Stock Pops Pre-Market As Domino’s ‘Hungry For More’ Strategy Drives 32nd Straight Year Of International Same-Store Sales Growth

Domino’s Pizza (DPZ) shares rose 6% premarket after Q4 results showed EPS of $5.35 on $1.54B revenue, beating estimates. The company reported 32nd straight year of international same-store sales growth and a 3.7% U.S. same-store sales increase. Domino’s raised its quarterly dividend by 15% to $1.99 per share, citing strong franchisee profits and market share gains.

stocktwits.com2 min